METHODS FOR ADMINISTERING THERAPEUTIC DOSES OF BISPECIFIC T-CELL ENGAGING MOLECULES FOR THE TREATMENT OF CANCER

Methods for the treatment of COVID-19 comprising administering replication-defective adenoviruses encoding the SARS-CoV-2 spike glycoprotein and modified nucleocapsid protein

ANTI COVID-19 THERAPIES USING NUCLEOCAPSID AND SPIKE PROTEINS

Method of inducing immunity against SARS-CoV-2 using spike and nucleocapsid-ETSD immunogens delivered by RNA and replication-defective adenoviruses

ACE2-Fc Trap

Replication-defective adenoviruses comprising nucleic acids encoding SARS-CoV-2 s glycoprotein and modified N protein comprising an endosomal targeting sequence

Chimeric proteins and their use in identifying anti-deubiquitinase compounds

METHODS FOR PURIFYING PROTEINS HAVING A TUBULIN CARBOXYPEPTIDASE ACTIVITY AND PEPTIDIC BASED INHIBITORS THEREOF

PNEUMOCOCCAL INHIBITORY FACTOR COMPOSITIONS AND METHODS OF USE THEREOF

Chimeric proteins and their use in identifying anti-deubiquitinase compounds

Pharmaceutical compositions containing peptides derived from human BPLP protein

Methods for treating pain by administering peptides derived from human basic proline-rich lacrimal protein

DPP-4 inhibitor

Peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity

Method for detecting human BPLP protein or a maturation product thereof

METHODS OF TREATMENT FOR PULMONARY FIBROSIS

NOVEL PEPTIDES FOR TREATING AND PREVENTING IMMUNE-RELATED DISORDERS, INCLUDING TREATING AND PREVENTING INFECTION BY MODULATING INNATE IMMUNITY

Peptides derived from human BPLP protein

Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity

Bioactive peptides derived from the proteins of egg white by means of enzymatic hydrolysis